Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04319848
PHASE1
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Sponsor: Singapore Eye Research Institute
View on ClinicalTrials.gov
Summary
Assessment of safety and efficacy of tissue-engineered corneal endothelial graft material generated using cultured human corneal endothelial cells for tissue-engineered endothelial keratoplasty (TE-EK).
Official title: Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)
Key Details
Gender
All
Age Range
21 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2017-12-01
Completion Date
2028-06
Last Updated
2025-09-12
Healthy Volunteers
No
Conditions
Interventions
OTHER
TE-EK treatment group
Transplantation of tissue-engineered endothelial graft through DSAEK procedure.
Locations (1)
Singapore Eye Research Institute
Singapore, Singapore